Question explored with the scientific record
Conversation so far
- 1 Any non pharmaceutical treatment for memory loss
- 2 Natural remedies for memory loss
- 3 Does methylene blue have beneficial effects for memory loss
Answered on this page ↓
Does methylene blue have beneficial effects for memory loss
Methylene blue has real biological reasons to think it could help memory, but the human evidence for memory loss is not in front of me, and the animal data is not a substitute.
The mechanism is plausible. In a mouse model of Alzheimer's, long-term low-dose methylene blue in the diet reduced amyloid-beta and improved learning and memory, apparently by boosting proteasome activity [1]. In rats with reduced brain blood flow, low-dose methylene blue was tested for memory retention and learning [2]. Methylene blue is also discussed as a tau aggregation inhibitor, a compound that blocks the tangled protein clumps seen in Alzheimer's brains [3][4]. That is a coherent story. It is also all animal and review-level work.
What is missing is the part that matters to a person with memory loss: a randomized human trial with a real clinical outcome. The records here include a small controlled trial of methylene blue in severe depression, not memory [7], and a lab study of its effect on a brain receptor [8]. Neither answers the question. The retrieval is thin on human memory outcomes.
| What we have | What it shows | What it cannot tell you |
|---|---|---|
| Mouse Alzheimer's model [1] | Less amyloid, better maze performance | Whether humans benefit |
| Rat low-blood-flow model [2] | Tested for memory retention | Whether humans benefit |
| Tau reviews [3][4] | Named as an aggregation inhibitor | Whether it slows disease |
Methylene blue is not a harmless supplement. It is a real drug with real effects, including on brain receptors [8] and on blood vessel function [6], and it carries a documented risk of serotonin toxicity when combined with serotonergic drugs [5]. Dosing and purity of over-the-counter product are unregulated.
My call: the mechanism is interesting and the human memory evidence is not established here, so I would not take it for memory loss outside a supervised trial. Confidence: low.
Sources used 8
-
Methylene Blue Reduces Aβ Levels and Rescues Early Cognitive Deficit by Increasing Proteasome Activity
This study demonstrates that chronic dietary administration of methylene blue reduces amyloid-beta levels and rescues early cognitive deficits in a transgenic mouse model of Alzheimer's disease by increasing proteasome activity.
DOI: 10.1111/j.1750-3639.2010.00430.x -
Therapeutic Benefits of Methylene Blue on Cognitive Impairment during Chronic Cerebral Hypoperfusion
This study investigates the cognitive benefits of low-dose methylene blue in rats with chronic cerebral hypoperfusion, demonstrating its potential to enhance memory retention and learning in a visual water task.
DOI: 10.3233/JAD-141527 -
Tau Oligomers as Potential Targets for Alzheimer’s Diagnosis and Novel Drugs
A discussion of tau oligomers as targets for Alzheimer’s diagnosis and therapy, highlighting peripheral platelet tau as a biomarker, tau aggregation inhibitors (including natural compounds like fulvic/Andean shilajit, methylene blue), and the potential for tau-focused interventi…
DOI: 10.3389/fneur.2013.00167 -
Tau in Alzheimer Disease and Related Tauopathies
A comprehensive, mechanistic review of tau biology in Alzheimer's disease and related tauopathies, detailing normal tau function, how abnormal hyperphosphorylation drives cytosolic tau toxicity and PHF/SF formation, the various model systems used to study tau pathology, and the …
DOI: 10.2174/156720510793611592 -
The monoamine oxidase inhibition properties of selected structural analogues of methylene blue
This study synthesizes and evaluates five structural analogues of methylene blue for their ability to inhibit human monoamine oxidases A and B in vitro, explores their binding by docking, and discusses implications for structure–activity relationships and serotonin toxicity risk.
DOI: 10.1016/j.taap.2017.03.026 -
Comparison of Cholinergic Vasodilator Responses to Acetylcholine and Methacholine in the Human Forearm
This study investigates the differential vasodilatory effects of acetylcholine and methacholine in the human forearm, highlighting the role of nitric oxide and the impact of methylene blue and L-NMMA on these responses.
DOI: 10.3109/08037059609078071 -
A controlled trial of methylene blue in severe depressive illness
This study investigates the efficacy of 15 mg/day methylene blue compared to placebo in treating severe depressive illness, finding significant improvement in patients receiving methylene blue.
DOI: 10.1016/0006-3223(87)90194-6 -
Methylene blue inhibits GABA A receptors by interaction with GABA binding site
This study investigates the inhibitory effects of methylene blue on GABA A receptors, demonstrating that it interacts with the GABA binding site and modulates GABAergic neurotransmission in both recombinant receptors and mouse hippocampal neurons.
DOI: 10.1016/j.neuropharm.2017.04.002